The luxury market may have cooled in China, but contemporary players are gaining ground with clever strategies aimed at ...

Minor consumer holidays don’t just appear out of nowhere. There’s a method to the madness—and it’s juicier than you’d think.

"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

So, in what translates into an awe-inspiring collaborative effort, The Stephen Siller Tunnel to Towers Foundation and Gerald ...

I want to thank the Red Bull family and hope we continue to be friends," Marquez said in December on Red Bull-owned ...

In a report released today, Justin Smith from Bernstein maintained a Buy rating on Roche Holding AG (RHHVF – Research Report), with a price ...

In a report released today, James Quigley from Goldman Sachs maintained a Sell rating on Roche Holding AG (RHHVF – Research Report), with a ...

Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit ...

We recently published a list of 10 Best Annual Dividend Stocks To Buy Now. In this article, we are going to take a look at where Roche Holding AG (OTC:RHHBY) stands against other best annual dividend ...

Shares of RHHBY opened at $39.25 on Thursday. Roche has a 52-week low of $29.20 and a 52-week high of $42.43. The company has a 50-day simple moving average of $36.22 and a 200-day simple moving ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

Roche reported 3% top-line growth for the full year, with constant currency growth of 7% on the top line, and 14% for operating profit. Management guided to mid-single-digit sales growth and high ...